0000950170-24-019434.txt : 20240223
0000950170-24-019434.hdr.sgml : 20240223
20240223165007
ACCESSION NUMBER: 0000950170-24-019434
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bausch Christoph Lawrence
CENTRAL INDEX KEY: 0001889981
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 24672220
MAIL ADDRESS:
STREET 1: 2100 E 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
BUSINESS PHONE: 605-679-6980
MAIL ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
ownership.xml
4
X0508
4
2024-02-21
0001833214
SAB Biotherapeutics, Inc.
SABS
0001889981
Bausch Christoph Lawrence
2100 E 54TH STREET NORTH
SIOUX FALLS
SD
57104
false
true
false
false
CHIEF OPERATING OFFICER
false
Employee Stock Option (right to buy)
5.17
2024-02-21
4
A
false
140000
0
A
2034-02-21
Common Stock
140000
140000
D
Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.
/s/ Christoph Bausch
2024-02-23